Ciprofloxacin and dexamethasone

NuCare Pharmaceutical, Inc.🇺🇸 United States

FDA Page

Effective Date: Mar 19, 2026
Approval ID: 4d650d9d-a98a-2dbe-e063-6294a90a0077
Products: 1 registered
Version: 1

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use CIPROFLOXACIN AND DEXAMETHASONE OTIC SUSPENSION safely and effectively. See full prescribing information for CIPROFLOXACIN AND DEXAMETHASONE OTIC SUSPENSION. CIPROFLOXACIN and DEXAMETHASONE otic suspension Initial U.S. Approval: 2003

Quick Stats

Total Products1

Labelers1

Label Sections17

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.